Back to Search Start Over

Emmaus Life Sciences' Endari receives Florida Medicaid Preferred Drug List approval

Source :
M2 EquityBites (EQB). March 30, 2022
Publication Year :
2022

Abstract

M2 EQUITYBITES-March 30, 2022-Emmaus Life Sciences' Endari receives Florida Medicaid Preferred Drug List approval (C)2022 M2 COMMUNICATIONS http://www.m2.com Emmaus Life Sciences, Inc. (OTCQX: EMMA), a US-based company involved in the [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 EquityBites (EQB)
Publication Type :
News
Accession number :
edsgcl.698726548